Biotech

All Articles

YolTech markets China legal rights to genetics editing and enhancing treatment for $29M

.4 months after Chinese genetics editing company YolTech Therapies took its own cholesterol levels d...

Addex stock climbs after Indivior provides to $300M for material

.Indivior is getting a small particle allosteric modulator designed to handle substance usage proble...

Molecular Allies modifies AML trial over 'suboptimal exposure'

.Molecular Companions has recognized "suboptimal direct exposure" to its own tetra-specific T-cell e...

Despite combined market, a venture capital rebirth can be coming in Europe: PitchBook

.While the biotech financial investment performance in Europe has actually decreased somewhat adheri...

8 months after a $213M fundraise, gene publisher Tome makes cuts

.After raising $213 thousand in 2023-- among the year's largest private biotech shots-- Volume Biosc...

BioMarin creates exec crew along with biotech veterinarians-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings and ...

Biopharma Q2 VC attacked highest level considering that '22, while M&ampA slowed

.Venture capital financing into biopharma cheered $9.2 billion throughout 215 deals in the 2nd fourt...

Bicara, Zenas seek IPOs to press late-phase assets toward market

.Bicara Therapeutics and also Zenas Biopharma have offered fresh impetus to the IPO market with fili...

Genentech to close cancer cells immunology research department

.Genentech is going to close its cancer immunology study division, and also device mind and renowned...

Kezar falls solid lump however to verify its own well worth in period 1 trial

.Kezar Life Sciences is dropping its unpromising period 1 sound tumor medicine as the biotech goes a...